BVNRY:OTCMKTS
Bavarian Nordic A/S - ADR
US$9.05
arrow_upward
+0.50%(+0.045) 1D
6월 26일, 오후 4시 0분 0초 GMT-4 · USD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoBVNRY의 주요 통계 생성 중...
시가
US$9.00
고가
US$9.05
저가
US$9.00
시가총액
21.55억
평균 거래량
2.78천
거래량
214.00
주가수익률
12.53
52주 최고가
US$13.00
52주 최저가
US$8.67
EPS
US$0.72
베타
1.38
유통 주식수
2.38억
직원 수
2천
시가
US$9.00
고가
US$9.05
저가
US$9.00
시가총액
21.55억
평균 거래량
2.78천
거래량
214.00
주가수익률
12.53
52주 최고가
US$13.00
52주 최저가
US$8.67
EPS
US$0.72
베타
1.38
유통 주식수
2.38억
직원 수
2천
뉴스 기사
웹 소스 기반
프로필
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination. Wikipedia
Bavarian Nordic A/S - ADR에 관한 정보